As the principal U.S. institution of higher education engaged in biomedical and bio-behavioral research within the Pacific basin, the University of Hawaii at Manoa (UHM) seeks continued support from the Research Centers in Minority Institutions (RCMI) Program of the National Institutes of Health, to further develop research excellence in biomedicine by establishing an interdisciplinary network aimed at linking basic sciences, clinical medicine and translational research discoveries, with the goal of Attain Lasting Optimal Health for All (ALOHA), and with specific emphasis on addressing health disparities in underserved minority populations. Designated the Bioscience Research Infrastructure Development for Grant Enhancement and Success (BRIDGES), the UHM RCMI Program for the 2012-2017 cycle will embrace the spirit and tenets of the NIH Roadmap by creating interdisciplinary collaborative research networks employing emerging technologies for basic, clinical and translational sciences. Specifically, the research activities focusing on Collaborations and Partnerships and Professional Development, and the infrastructure cores in proteomics, magnetic resonance imaging, electrophysiology and behavior, microscopy, histopathology, human tissue biorepositories, bioinformatics, biostatistics and research ethics will rely heavily on interdisciplinary collaborations and intellectual exchange between basic scientists and clinicians, applying knowledge of human biology, physiology, biochemistry, molecular biology and fundamental principles of physics and chemistry, to develop novel and improved disease-specific diagnostic tests, therapeutic interventions and preventive strategies for health disparities of regional and national importance. These activities are designed to closely complement the basic science, clinical and patient-oriented activities of the RCMI Clinical Translational Research Center, (RCTR RMATRIX), the Center for Native and Pacific Health Disparities Research (CNPHDR), the Hawaii Statewide Research and Education Partnership (INBRE HSREP), and the Centers of Biomedical Research Excellence (COBRE). The RCMI BRIDGES Program will better position UHM to participate fully in the RCMI Translational Research Network and to ultimately secure a Clinical and Translational Sciences Award. Strong leadership has been identified for each of the Activities and Cores. Finally, complementary technical cores are being developed and expanded to achieve greater success in competing for mainstream extramural NIH funding for research and training.

Public Health Relevance

The overall objectives of the RCMI Program at UHM are to create and strengthen expertise, education, training and infrastructure for biomedical and behavioral research that promises to improve the diagnosis, prevention, and treatment of diseases, especially those associated with health disparities in minority populations in Hawaii.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Research Centers in Minority Institutions Award (G12)
Project #
2G12RR003061-26
Application #
8268628
Study Section
Special Emphasis Panel (ZRR1-RI-B (02))
Program Officer
Cooper, Leslie
Project Start
1997-09-01
Project End
2016-07-31
Budget Start
2011-09-16
Budget End
2012-07-31
Support Year
26
Fiscal Year
2011
Total Cost
$2,035,599
Indirect Cost
Name
University of Hawaii
Department
Anatomy/Cell Biology
Type
Schools of Medicine
DUNS #
965088057
City
Honolulu
State
HI
Country
United States
Zip Code
96822
Priemer, David S; Wang, Mingsheng; Zhang, Shaobo et al. (2018) Small-cell Carcinomas of the Urinary Bladder and Prostate: TERT Promoter Mutation Status Differentiates Sites of Malignancy and Provides Evidence of Common Clonality Between Small-cell Carcinoma of the Urinary Bladder and Urothelial Carcinoma. Eur Urol Focus 4:880-888
Marciel, Michael P; Rose, Aaron H; Martinez, Verena et al. (2018) Calpain-2 inhibitor treatment preferentially reduces tumor progression for human colon cancer cells expressing highest levels of this enzyme. Cancer Med 7:175-183
Marciel, Michael P; Khadka, Vedbar S; Deng, Youpeng et al. (2018) Selenoprotein K deficiency inhibits melanoma by reducing calcium flux required for tumor growth and metastasis. Oncotarget 9:13407-13422
Pomozi, Viola; Brampton, Christopher; Szeri, Flóra et al. (2017) Functional Rescue of ABCC6 Deficiency by 4-Phenylbutyrate Therapy Reduces Dystrophic Calcification in Abcc6-/- Mice. J Invest Dermatol 137:595-602
Norton, Robert L; Fredericks, Gregory J; Huang, Zhi et al. (2017) Selenoprotein K regulation of palmitoylation and calpain cleavage of ASAP2 is required for efficient Fc?R-mediated phagocytosis. J Leukoc Biol 101:439-448
Baumer, Yvonne; McCurdy, Sara; Weatherby, Tina M et al. (2017) Hyperlipidemia-induced cholesterol crystal production by endothelial cells promotes atherogenesis. Nat Commun 8:1129
Wilcox, Christie L; Headlam, Jasmine L; Doyle, Thomas K et al. (2017) Assessing the Efficacy of First-Aid Measures in Physalia sp. Envenomation, Using Solution- and Blood Agarose-Based Models. Toxins (Basel) 9:
Yanagihara, Angel Anne; Wilcox, Christie L (2017) Cubozoan Sting-Site Seawater Rinse, Scraping, and Ice Can Increase Venom Load: Upending Current First Aid Recommendations. Toxins (Basel) 9:
Chang, Linda; Løhaugen, Gro C; Andres, Tamara et al. (2017) Adaptive working memory training improved brain function in human immunodeficiency virus-seropositive patients. Ann Neurol 81:17-34
Doyle, Thomas K; Headlam, Jasmine L; Wilcox, Christie L et al. (2017) Evaluation of Cyanea capillata Sting Management Protocols Using Ex Vivo and In Vitro Envenomation Models. Toxins (Basel) 9:

Showing the most recent 10 out of 347 publications